NHS England and NHS Improvement (NHSE&I), in association with the Royal Pharmaceutical Society (RPS) and the Association of Pharmacy Technicians UK (APTUK) has published its first Inclusive Pharmacy Practice (IPP) Bulletin. As a member of the IPP Improving Practice and Engagement Group, PSNC has contributed to this issue of the Bulletin, which focuses on how [...]
Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 9 new products will be classed as ‘Drugs for which Discount is Not Deducted’ (DND) from 1 July 2022. This takes the total number of products granted DND status over the past 2 [...]
The post Over 500 products added to DND list in past 2 years appeared first on PSNC Website.
Community pharmacy contractors are not required to submit their completed New Medicine Service (NMS) summary data to the NHS Business Services Authority for April to June 2022 as this requirement has been postponed again for this quarter. In December, PSNC advised that this requirement, which was suspended during the pandemic, would be re-instated from Quarter [...]
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Eletriptan (Relpax®) 20mg tablets. MSN/2022/058 Tier 2 – medium impact Date of issue 30th June 2022 Eletriptan (Relpax®) 20mg tablets are out of stock until w/c 1st Aug 2022. Alternative triptans remain available and can support the increased demand. A copy [...]
The post Medicine Supply Notification: Eletriptan (Relpax® ) 20mg tablets appeared first on PSNC Website.
Key point summary The COVID-19 vaccination draft service specification to support provision of a booster programme in the autumn has been published by NHS England and NHS Improvement (NHSE&I); The service will be commissioned as a National Enhanced Service (NES)*, with community pharmacy contractors being selected locally to provide the service to meet population needs; [...]